Skip to main content

Table 3 Estimate of variation in presence of depressive symptoms and antidepressant medication use over time

From: Marginal structural models for the estimation of the risk of Diabetes Mellitus in the presence of elevated depressive symptoms and antidepressant medication use in the Women’s Health Initiative observational and clinical trial cohorts

 

WHI-OS N = 68,169

 

Antidepressant use at baseline

No antidepressant use at baseline

 

N (%)

N (%)

Antidepressant use at year 3

3321 (4.9 %)

3083 (4.5 %)

No antidepressant use at year 3

1468 (2.2 %)

60297 (88.5 %)

 

Presence of elevated symptoms at baseline

No presence of elevated symptoms at baseline

 

N (%)

N (%)

Presence of elevated symptoms at year 3

4348 (6.4 %)

6333 (9.3 %)

No presence of elevated symptoms at year 3

5458 (8.0 %)

52030 (76.3 %)

 

Baseline

Year 3

 

Mean (SD)

Mean (SD)

BMI

26.80 (5.5)

27.09 (5.6)

 

WHI-CT N = 52,326

 

Antidepressant use at baseline

No antidepressant use at baseline

 

N (%)

N (%)

Antidepressant use at year 3

2031 (3.9 %)

1979 (3.8 %)

No antidepressant use at year 3

1156 (2.2 %)

47160 (90.1 %)

 

Baseline

Year 3

 

Mean (SD)

Mean (SD)

BMI

28.54 (5.7)

28.78 (5.9)